HRMY   $27.96  -0.18% Market Closed After Close 27.88 -0.29%

Harmony Biosciences Holdings, Inc.
Total Cash 410.48M
totalCashPerShare 7.197
EBITDA 199.56M
Total Debt 185.24M
quickRatio 3.05
currentRatio 3.239
Total Revenue 681.88M
debtToEquity 31.039
Revenue/Share 11.923
ROA 0.12845
ROE 0.22748
grossProfits
freeCashflow 168.65M
operatingCashflow 220.92M
earningsGrowth 0.25
revenueGrowth 0.161
grossMargins 0.78653
ebitdaMargins 0.29267
operatingMargins 0.33171
profitMargins 0.17983
enterpriseValue 1.68B
forwardPE 10.583334
floatShares 34.86M
sharesOutstanding 57.03M
sharesShort 7.45M
sharesShortPriorMonth 8.41M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.93%
Short Ratio help_outline 12.09%
shortPercentOfFloat 0.58%
impliedSharesOutstanding
bookValue 10.465
Price To Book help_outline 3.28
earningsQuarterlyGrowth 0.20
netIncomeToCommon 122.62M
trailingEps 2.11%
forwardEps 3.24%
enterpriseToEbitda 8.42
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.7 4Q 2024
institutionsCount 326
lastUpdated Nov. 7, 2024, 3:21 a.m.